Emerade Injection; Device Failure
Emerade Injection (0.3 mg/0.3 mL and 0.5 mg/0.5 mL) is being recalled across Canada because the device may fail to work properly. This is a Class I recall, meaning there is a serious risk to health. The recall affects all Emerade injections distributed in Canada.
- Product
- Emerade Injection (0.3 mg / 0.3 mL and 0.5 mg / 0.5 mL)
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-05-08
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/7686bbf0-dee0-4e25-b1ef-3200cf2fb370